[Therapy of chronic hepatitis C: facing a breakthrough?].
Renner
E L
EL
Abteilung für Gastroenterologie, Universitätsspital, Zürich.
D000547:Amantadine / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D019698:Hepatitis C, Chronic / Q000628:therapy* / Q000821:virology; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012008:Recurrence; D012254:Ribavirin / Q000008:administration & dosage*; D019562:Viral Load
D007370:Interferon Type I; D011994:Recombinant Proteins; D012254:Ribavirin; D000547:Amantadine
Therapie der chronischen Hepatitis C: Vor dem Durchbruch?